Patisiran treatment for ATTR cardiac amyloidosis: 18-month results of the phase 3 APOLLO-B study

Autor: Fontana, M. 1, L Berk, J. 2, Hanna, M. 3, D Gillmore, J. 4, Pedro-Schwartzmann, V. 5, Lairez, O. 6, ⁎, Hyun-Jai, C. 7, Van Der Meer, P. 8, White, M.T. 9, Elena, Y. 10, Sweetser, M.T. 11, Jay, P.Y. 11, Vest, J. 12, S Maurer, M. 13
Zdroj: In Archives of Cardiovascular Diseases January 2024 117(1) Supplement:S34-S35
Databáze: ScienceDirect
Externí odkaz: